Theseus Pharmaceuticals, Inc.

Ownership Transactions Reported by 17 Insiders

Location
314 Main Street, Suite 04 200, Cambridge, MA

There are no Buy or Sell transactions made by insiders since 11/5/2023

Theseus Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Takeda Pharmaceutical Co Ltd 10%+ Owner $4.93M Oct 12, 2021
Foresite Capital Management V, LLC 10%+ Owner $4.23M Jul 17, 2023
Omega Fund VI, L.P. Former 10% owner $2.17M Oct 12, 2021
William Shakespeare President of Research and Development $2.02M Nov 6, 2023
Rock Springs Capital Management LP 10%+ Owner $1.83M Oct 12, 2021
Timothy P. Clackson President and CEO, Director $139K Mar 1, 2023
David Kerstein Chief Medical Officer $53.4K Mar 1, 2023
Victor Rivera Chief Scientific Officer $49.6K Mar 1, 2023
Donald J. Hayden Jr Director $0 Feb 14, 2024
Kathy Yi Director $0 Feb 14, 2024
Carl L. Gordon Director, 10%+ Owner $0 Feb 14, 2024
Orbimed Advisors Llc Director, 10%+ Owner $0 Feb 14, 2024
Iain Dukes Director $0 Feb 14, 2024
Steven H. Stein Director $0 Feb 14, 2024
D. Dahms President and CFO $0 Feb 14, 2024
David Dalgarno Chief Technical Officer Feb 18, 2022
Michael E. Rome Director Oct 6, 2021

Recent Insider Transactions by Companies or Individuals for Theseus Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.